Use of PBPK modeling to reduce uncertainty in risk assessment: Example of manganese
111010Hamner.pdf
(1.66 MB)
Document Date:
Document Keywords
physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetics (PBPK)
manganese
Document Category
Presentation
Meeting
Biomonitoring California Scientific Guidance Panel Meeting, November 2010
